← FDA Drug Approvals (Drugs@FDA)
LUBIPROSTONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS · Approved 2022-02-08
Drug application
- FDA Application #
ANDA206994- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LUBIPROSTONE
- Generic name
- Lubiprostone
- Active ingredients
- LUBIPROSTONE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- DR REDDYS
- First approval
- 2022-02-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown